For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

By Ludwig Burger (Reuters) -Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff ...

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.

A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal ...

"This FDA Breakthrough Device Designation underscores the potential of our computational pathology platform to enable more personalised treatment decisions for people with cancer,” said Susan ...

Swiss pharmaceuticals powerhouse Roche announced Tuesday it plans to invest $50 billion in the United States over the next ...